Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.50 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CCNC | P24863 | 1/20 | 0.42 |
| ▸ | CDK8 | P49336 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | MDM4 | O15151 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15514 | 1.00 | TYR (0.50) | TYRTTRDPP4CA12CA1 | |
| SCHEMBL7183094 | 0.90 | TYR (0.48) | TYRTTRDPP4CA12CA1 | |
| SCHEMBL29693828 | 0.90 | TYR (0.48) | TYRTTRDPP4CA12CA1 | |
| SCHEMBL14342903 | 0.90 | TYR (0.48) | TYRTTRDPP4CA12CA1 | |
| Ethyl Cinnamate SCHEMBL28948990 | 0.89 | KDM4E (0.48) | TYRTTRDPP4CA12CA1 | |
| Ethyl Cinnamate SCHEMBL28948991 | 0.89 | KDM4E (0.48) | TYRTTRDPP4CA12CA1 | |
| Isopropyl 3-(4-Isopropylphenyl)Acrylate SCHEMBL28558517 | 0.89 | CA12 (0.48) | TYRTTRDPP4CA12CA1 | |
| SCHEMBL645927 | 0.84 | ALDH1A1 (0.48) | TYRTTRCA12CA1CA2 | |
| SCHEMBL157462 | 0.84 | ALDH1A1 (0.48) | TYRTTRCA12CA1CA2 | |
| SCHEMBL29435132 | 0.84 | ALDH1A1 (0.48) | TYRTTRCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | ITO, KABUSIKIKAISYA (JP) | 2023-02-23 | — | — | US | claimed |
| CN-101282708-B | External preparation for skin containing a phosphorlated saccharide | EZAKI GLICO CO | 2013-03-20 | — | — | CN | claimed |
| US-8168227-B2 | Modified powder and cosmetic composition using the same | SHISEIDO CO., LTD. (JP) | 2012-05-01 | — | — | US | claimed |
| US-20070253989-A1 | Modified Powder and Cosmetic Composition Using the Same | SHISEIDO CO., LTD. (JP) | 2007-11-01 | — | — | US | claimed |
| US-12564549-B2 | Cleanser composition | SHISEIDO COMPANY, LTD. (JP) | 2026-03-03 | — | — | US | disclosed |
| US-20250295566-A1 | DIESTER HAIR STYLING FORMULATIONS, AND USES THEREOF | Chembeau LLC | 2025-09-25 | — | — | US | disclosed |
| US-20250248913-A1 | HAIR TREATMENT FORMULATIONS AND USES THEREOF | Chembeau LLC | 2025-08-07 | — | — | US | disclosed |
| US-20250177270-A1 | DIESTER COSMETIC FORMULATIONS AND USES THEREOF | Chembeau LLC | 2025-06-05 | — | — | US | disclosed |
| US-12285508-B2 | Hair treatment formulations and uses thereof | Chembeau LLC (US) | 2025-04-29 | — | — | US | disclosed |
| US-12214065-B2 | Diester cosmetic formulations and uses thereof | Chembeau LLC (US) | 2025-02-04 | — | — | US | disclosed |
| US-12059489-B2 | Oil-in-water type dermatological composition for external use | SHISEIDO COMPANY, LTD. (JP) | 2024-08-13 | — | — | US | disclosed |
| CN-113164433-B | Oily moisturizer and external composition for skin containing same | 日清奥利友集团株式会社 | 2024-07-09 | — | — | CN | disclosed |
| EP-0814758-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | Kao Corporation (JP) | 1998-01-07 | — | — | EP | disclosed |
| WO-1996028137-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | KAO CORPORATION (JP) | 1996-09-19 | — | — | WO | disclosed |
| EP-0721484-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | Kao Corporation (JP) | 1996-07-17 | — | — | EP | disclosed |
| EP-0688559-A1 | Skin anti-ageing composition | SHISEIDO COMPANY LIMITED (JP) | 1995-12-27 | — | — | EP | disclosed |
| US-5427771-A | Stable dispersion in cosmetically acceptable vehicle with adjuvants | L'OREAL (FR) | 1995-06-27 | — | — | US | disclosed |
| WO-1995009895-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | KAO CORPORATION (JP) | 1995-04-13 | — | — | WO | disclosed |
| US-5000937-A | Transparent cosmetic composition that reflects infrared radiation and its use for protecting the human epidermis against infrared radiation | L'OREAL (FR) | 1991-03-19 | — | — | US | disclosed |
| EP-0211183-A2 | Use of ubidecarenone(ubiquinone-10) as an antichromatotic agent | Eisai Co., Ltd. (JP) | 1987-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12214065-B2 | Diester cosmetic formulations and uses thereof | DAGLA, CYP19A1, CYP51A1 | TYR 17/4885TTR 2293/4885DPP4 3292/4885 |
| US-20250295566-A1 | DIESTER HAIR STYLING FORMULATIONS, AND USES THEREOF | SUCLG1, SMS, SRM | TYR 93/4885TTR 1430/4885DPP4 4453/4885 |
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | CTSA, ATG4A, ATG7 | TYR 3775/4885TTR 4774/4885DPP4 539/4885 |
| US-12564549-B2 | Cleanser composition | LIPA, SGMS1, SGMS2 | TYR 4713/4885TTR 1002/4885DPP4 4589/4885 |
| US-20250248913-A1 | HAIR TREATMENT FORMULATIONS AND USES THEREOF | FHIT, SUCLG1, TES | TYR 4/4885TTR 1861/4885DPP4 4367/4885 |
| US-12285508-B2 | Hair treatment formulations and uses thereof | FHIT, SUCLG1, TES | TYR 4/4885TTR 1861/4885DPP4 4367/4885 |
| US-20250177270-A1 | DIESTER COSMETIC FORMULATIONS AND USES THEREOF | DAGLA, CYP19A1, CYP51A1 | TYR 17/4885TTR 2293/4885DPP4 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.